Compared to healthy individuals, MS patients, both with and without calciphylaxis, exhibit elevated basal expression levels of hypoxia-related proteins (GLUT1 and VEGF), with the highest levels observed in those with calciphylaxis (182). The gene discussed is SLC2A1; the disease is myeloid sarcoma.